(Q37784646)

23 August 2017

title

Translational medicine and the value of biomarker qualification (English)

1 reference

23 August 2017

0 references

translational medicine

1 reference

Federico M Goodsaid

1

1 reference

23 August 2017

Donna L Mendrick

series ordinal

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

Science Translational Medicine

23 August 2017

published in

1 reference

23 August 2017

volume

2

1 reference

23 August 2017

issue

47

1 reference

23 August 2017

page(s)

47ps44

1 reference

Mechanistic biomarkers for cytotoxic acute kidney injury

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001040

Voluntary exploratory data submissions to the US FDA and the EMA: experience and impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001040

Creatinine as the gold standard for kidney injury biomarker studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001040

A guidance for renal biomarker lead optimization and use in translational pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001040

The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001040

Genomic and genetic biomarkers of toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001040

Towards consensus practices to qualify safety biomarkers for use in early drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001040

10.1126/SCITRANSLMED.3001040

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference